For: | Yamamoto-Furusho JK, Parra-Holguín NN. Emerging therapeutic options in inflammatory bowel disease. World J Gastroenterol 2021; 27(48): 8242-8261 [PMID: 35068868 DOI: 10.3748/wjg.v27.i48.8242] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i48/8242.htm |
Number | Citing Articles |
1 |
Yijie Song, Yihao He, Lan Rong, Zhicheng Wang, Yueming Ma, Ning Zhang, Bing Wang. “Platelet-coated bullets” biomimetic nanoparticles to ameliorate experimental colitis by targeting endothelial cells. Biomaterials Advances 2023; 148: 213378 doi: 10.1016/j.bioadv.2023.213378
|
2 |
Peng Zhang, Hua Jiang. Acetyl‐11‐keto‐β‐boswellic Acid Confers Protection in DSS‐Induced Colitis via the JNK–p38 MAPK and NF‐κB Signaling Pathways. Advanced Biology 2023; 7(6) doi: 10.1002/adbi.202200247
|
3 |
Jing Zhang, Ze Li, Ying Zhang, Yi-lei Guo, Yan-rong Zhu, Wen-xin Xia, Yue Dai, Yu-feng Xia. Mume Fructus (Prunus mume Sieb. et Zucc.) extract accelerates colonic mucosal healing of mice with colitis induced by dextran sulfate sodium through potentiation of cPLA2-mediated lysophosphatidylcholine synthesis. Phytomedicine 2023; 119: 154985 doi: 10.1016/j.phymed.2023.154985
|
4 |
Aditi Kumar, Philip J Smith. Horizon scanning: new and future therapies in the management of inflammatory bowel disease. eGastroenterology 2023; 1(2): e100012 doi: 10.1136/egastro-2023-100012
|
5 |
Pardis Mansouri, Pegah Mansouri, Esmaeil Behmard, Sohrab Najafipour, Amin Kouhpayeh, Akbar Farjadfar. Novel targets for mucosal healing in inflammatory bowel disease therapy. International Immunopharmacology 2025; 144: 113544 doi: 10.1016/j.intimp.2024.113544
|
6 |
Carina de F. de Síbia, Ana E. V. Quaglio, Ellen C. S. de Oliveira, Jéssica N. Pereira, Jovita R. Ariede, Rainer M. L. Lapa, Fábio E. Severino, Patricia P. Reis, Lígia Y. Sassaki, Rogerio Saad-Hossne. microRNA–mRNA Networks Linked to Inflammation and Immune System Regulation in Inflammatory Bowel Disease. Biomedicines 2024; 12(2): 422 doi: 10.3390/biomedicines12020422
|
7 |
Li Chen, Tingying Jiao, Weiwei Liu, Yuhong Luo, Jue Wang, Xiaozhen Guo, Xiao Tong, Zemin Lin, Chuying Sun, Kanglong Wang, Yifan He, Yuwei Zhang, Hualing Xu, Jiawen Wang, Jianping Zuo, Qiurong Ding, Shijun He, Frank J. Gonzalez, Cen Xie. Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal. Cell Stem Cell 2022; 29(9): 1366 doi: 10.1016/j.stem.2022.08.008
|
8 |
Anisha Apte, Pujarini Dutta Dey, Srisaianirudh Reddy Julakanti, Monica Midura-Kiela, Stacy M. Skopp, Jimena Canchis, Tobias Fauser, James Bardill, Sudipta Seal, David M. Jackson, Fayez K. Ghishan, Pawel R. Kiela, Carlos Zgheib, Kenneth W. Liechty. Oral Delivery of miR146a Conjugated to Cerium Oxide Nanoparticles Improves an Established T Cell-Mediated Experimental Colitis in Mice. Pharmaceutics 2024; 16(12): 1573 doi: 10.3390/pharmaceutics16121573
|
9 |
Ayushi Mairal, Shreya Mehrotra, Anupam Kumar, Rakhi Maiwal, Jan Marsal, Ashok Kumar. Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device. ACS Applied Materials & Interfaces 2024; 16(5): 5382 doi: 10.1021/acsami.3c14113
|
10 |
Yatian Yang, Chengcheng Qian, Rui Wu, Rui Wang, Jinmei Ou, Shoujin Liu. Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-022-03823-7
|
11 |
J.K. Yamamoto-Furusho, J.G. López-Gómez, F.J. Bosques-Padilla, M.A. Martínez-Vázquez, J.L. De-León-Rendón. Primer consenso mexicano de la enfermedad de Crohn. Revista de Gastroenterología de México 2024; 89(2): 280 doi: 10.1016/j.rgmx.2024.03.003
|
12 |
Sanjay Singh. Antioxidant nanozymes as next-generation therapeutics to free radical-mediated inflammatory diseases: A comprehensive review. International Journal of Biological Macromolecules 2024; 260: 129374 doi: 10.1016/j.ijbiomac.2024.129374
|
13 |
Jingjing Ma, Simei Yue, Yinghui Liu, Lingjiao Gong, Pengzhan He, Yingjie Yang, Zhengxin Fu, Danxiang Han, Qiang Hu, Fei Liao, Lin Xu. Fucoxanthin ameliorates ulcerative colitis by maintaining the epithelial barrier via blocking JAK2/STAT3 signaling pathway. Toxicology and Applied Pharmacology 2025; 495: 117213 doi: 10.1016/j.taap.2024.117213
|
14 |
Chen Kong, Meifeng Yang, Ningning Yue, Yuan Zhang, Chengmei Tian, Daoru Wei, Ruiyue Shi, Jun Yao, Lisheng Wang, Defeng Li. Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy. Journal of Inflammation Research 2024; : 5389 doi: 10.2147/JIR.S470520
|
15 |
Wanwan Zhu, Tianhao Zhao, Jun Wei, Damin Chai, Cancan Zhao, Yu Zhu, Min Deng. Case report: Eosinophilic pneumonia associated with vedolizumab therapy in a patient with ulcerative colitis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.942237
|
16 |
J.K. Yamamoto-Furusho, J.G. López-Gómez, F.J. Bosques-Padilla, M.A. Martínez-Vázquez, J.L. De-León-Rendón. First Mexican Consensus on Crohn’s disease. Revista de Gastroenterología de México (English Edition) 2024; 89(2): 280 doi: 10.1016/j.rgmxen.2024.03.001
|
17 |
Aldona Kasprzak, Agnieszka Adamek. Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related Cancers. International Journal of Molecular Sciences 2022; 23(19): 11188 doi: 10.3390/ijms231911188
|
18 |
Zihan Ding, Maorong Jiang, Jiaxi Qian, Dandan Gu, Huiyuan Bai, Min Cai, Dengbing Yao. Role of transforming growth factor-β in peripheral nerve regeneration. Neural Regeneration Research 2024; 19(2): 380 doi: 10.4103/1673-5374.377588
|